← 產業報告目錄

Orthopaedic Soft Tissue Repair Market Research Report information, By Application (Shoulder (Rotator Cuff Tears, Biceps Tendonitis, and Others), Knee (ACL Injuries, Meniscal Tears, Collateral Ligament Injuries, and Others), Hip (Hip Tendonitis, Labral Tears, and Others), Foot and Ankle (Plantar Fasciitis, Achilles Tendon Ruptures, Tibial Tendon Dysfunction, and Others)), End User (Hospitals, Ambulatory Surgical Centers, and Specialty Orthopaedic Clinics), Region (North America, Europe, Asia-Pacific, South America, and Middle East & Africa) Forecast to 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-05-15頁數 196報告編號 MRFRHC44628CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Orthopaedic Soft Tissue Repair Market Research Report information, By Application (Shoulder (Rotator Cuff Tears, Biceps Tendonitis, and Others), Knee (ACL Injuries, Meniscal Tears, Collateral Ligament Injuries, and Others), Hip (Hip Tendonitis, Labral Tears, and Others), Foot and Ankle (Plantar Fasciitis, Achilles Tendon Ruptures, Tibial Tendon Dysfunction, and Others)), End User (Hospitals, Ambulatory Surgical Centers, and Specialty Orthopaedic Clinics), Region (North America, Europe, Asia-Pacific, South America, and Middle East & Africa) Forecast to 2032 Overview of the Market In 2023, the orthopedic soft tissue repair market was estimated to be worth USD 7,844.52 million. Over the course of the projection period, the industry is expected to increase at a compound annual growth rate (CAGR) of 8.98%. The market is expanding because to an increase in orthopaedic surgery and sports-related injuries. The global orthopaedic soft tissue repair market is expanding at a rapid pace because to the increased prevalence of sports-related injuries. Injuries to soft tissues including ligaments, tendons, and muscles are becoming more common as sports participation rises worldwide, particularly among professional athletes and amateur sports fans. ACL tears, rotator cuff injuries, and Achilles tendon ruptures are among the typical soft tissue injuries that are most frequently linked to high-impact and contact sports like football, basketball, soccer, and tennis. Perspectives on Market Segments The orthopaedic soft tissue repair market has been divided into segments based on application: should, knee, hip, foot, and ankle. The Orthopaedic Soft Tissue Repair Market has been divided into three segments based on the end user: specialist orthopaedic clinics, ambulatory surgical centers (ASCS), and hospitals. Regional Perspectives North America, Europe, Asia-Pacific, and the Rest of the World are the regions into which the Orthopaedic Soft Tissue Repair Market has been divided. In 2024, North America held the biggest market share, which it is expected to maintain throughout the forecast period. Nonetheless, over the course of the forecast period, Asia-Pacific is anticipated to develop at the greatest CAGR. The market for orthopaedic soft tissue repair in North America is expanding rapidly due to several important factors, such as an aging population, an increase in sports-related injuries, a growing need for minimally invasive surgeries, and advancements in surgical and implant technologies. Additionally, during the forecast period, the orthopedic soft tissue repair market in Europe is anticipated to grow significantly. The market is fueled by the presence of significant players who depend on product innovations, strategic alliances, and innovation to maintain their market share. Due to an increase in musculoskeletal issues and disposable income, the orthopedic soft tissue repair market in Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. The market for orthopedic soft tissue repair in the area is seeing significant potential opportunities due to the growing presence of regional manufacturers of medical equipment. Over the course of the forecast year, the orthopedic soft tissue repair market in MEA is anticipated to grow significantly. Early detection and prevention of sports-related injuries are major concerns of the growing number of sports medical institutions in both developed and developing nations. Important Market Participants Braun SE (Germany), Xiros Ltd. (UK), Zimmer Biomet (US), CONMED Corporation (US), Arthrex, Inc. (US), Johnson & Johnson Inc. (US), Integra Lifesciences Holdings Corporation (US), Stryker (US), Smith+Nephew (UK), and Boston Scientific Corporation (US) are important players in the orthopaedic soft tissue repair market.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ............................................................................................................. 21 2 STUDY INTRODUCTION .............................................................................................................. 23 2.1 DEFINITION ........................................................................................................................................................... 23 2.2 SCOPE OF THE STUDY ......................................................................................................................................... 23 2.3 RESEARCH OBJECTIVE ........................................................................................................................................ 23 2.4 MARKET STRUCTURE ......................................................................................................................................... 24 3 RESEARCH METHODOLOGY ...................................................................................................... 25 3.1 OVERVIEW ............................................................................................................................................................ 25 3.2 DATA FLOW .......................................................................................................................................................... 27 3.2.1 DATA MINING PROCESS ................................................................................................................................. 27 3.3 PURCHASED DATABASE: .................................................................................................................................... 28 3.4 SECONDARY SOURCES: ...................................................................................................................................... 29 3.4.1 SECONDARY RESEARCH DATA FLOW: ............................................................................................................. 30 3.5 PRIMARY RESEARCH: ......................................................................................................................................... 31 3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................................................................................. 32 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: .......................................................................................... 33 3.6.1 REVENUE ANALYSIS APPROACH ..................................................................................................................... 33 3.7 DATA FORECASTING........................................................................................................................................... 34 3.7.1 DATA FORECASTING TYPE .............................................................................................................................. 34 3.8 DATA MODELING ................................................................................................................................................ 35 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ............................................................................................................ 35 3.8.2 DATA MODELING: ........................................................................................................................................... 36 3.9 TEAMS AND ANALYST CONTRIBUTION ......................................................................................................... 38 4 MARKET DYNAMICS .................................................................................................................... 40 4.1 INTRODUCTION ................................................................................................................................................... 40 4.2 DRIVERS ................................................................................................................................................................. 41 4.2.1 RISING SPORTS-RELATED INJURIES ................................................................................................................ 41 4.2.2 INCREASING NUMBER OF ORTHOPAEDIC SURGERIES ...................................................................................... 41 4.2.3 INCREASING INNOVATIVE SOFT TISSUE REPAIR IMPLANT DEVICES AND SYSTEMS .......................................... 42 4.3 RESTRAINTS .......................................................................................................................................................... 43 4.3.1 SHORTAGES OF SKILLED ORTHOPAEDIC SURGEON ......................................................................................... 43 4.3.2 HIGH COST OF PROCEDURES AND DEVICES ..................................................................................................... 44 4.4 OPPORTUNITY ..................................................................................................................................................... 45 4.4.1 GROWING GERIATRIC POPULATION ................................................................................................................ 45 4.4.2 INCREASING FUNDING AND INVESTMENT ASSOCIATED WITH ORTHOPAEDIC SOFT TISSUE REPAIR .................. 45 4.4.3 GROWING LAUNCH OF SOFT TISSUE REPAIR IMPLANT PRODUCTS................................................................... 46 5 MARKET FACTOR ANALYSIS ...................................................................................................... 47 5.1 PORTER'S FIVE FORCES MODEL ....................................................................................................................... 47 5.1.1 THREAT OF NEW ENTRANTS ........................................................................................................................... 47 5.1.2 BARGAINING POWER OF SUPPLIERS ............................................................................................................... 48 5.1.3 THREAT OF SUBSTITUTES .............................................................................................................................. 48 5.1.4 BARGAINING POWER OF BUYERS .................................................................................................................... 48 5.1.5 INTENSITY OF RIVALRY .................................................................................................................................. 48 5.2 IMPACT OF COVID-19 ON GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET ............................ 49 6 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION ......................... 51 6.1 INTRODUCTION ................................................................................................................................................... 51 6.2 SHOULDER ............................................................................................................................................................ 55 6.2.1 ROTATOR CUFF TEARS ................................................................................................................................... 56 6.2.2 BICEPS TENDONITIS ....................................................................................................................................... 56 6.2.3 OTHERS ......................................................................................................................................................... 57 6.3 KNEE ....................................................................................................................................................................... 57 6.3.1 ACL INJURIES ................................................................................................................................................. 58 6.3.2 MENISCAL TEARS ........................................................................................................................................... 59 6.3.3 COLLATERAL LIGAMENT INJURIES.................................................................................................................. 59 6.3.4 OTHERS ......................................................................................................................................................... 60 6.4 HIP .......................................................................................................................................................................... 60 6.4.1 HIP TENDONITIS............................................................................................................................................. 61 6.4.2 LABRAL TEARS ............................................................................................................................................... 62 6.4.3 OTHERS ......................................................................................................................................................... 62 6.5 FOOT AND ANKLE ............................................................................................................................................... 63 6.5.1 PLANTAR FASCIITIS ....................................................................................................................................... 64 6.5.2 ACHILLES TENDON RUPTURES ........................................................................................................................ 64 6.5.3 TIBIAL TENDON DYSFUNCTION ....................................................................................................................... 65 6.5.4 OTHERS ......................................................................................................................................................... 65 7 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER .............................. 66 7.1 INTRODUCTION ................................................................................................................................................... 66 7.2 HOSPITALS ............................................................................................................................................................ 68 7.3 AMBULATORY SURGICAL CENTERS (ASCS) ................................................................................................... 69 7.4 SPECIALTY ORTHOPAEDIC CLINICS ............................................................................................................... 69 8 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY REGION .................................. 70 8.1 OVERVIEW ............................................................................................................................................................ 70 8.2 NORTH AMERICA ................................................................................................................................................ 72 8.2.1 US.................................................................................................................................................................. 78 8.2.2 CANADA ........................................................................................................................................................ 81 8.3 EUROPE .................................................................................................................................................................. 86 8.3.1 GERMANY ...................................................................................................................................................... 92 8.3.2 FRANCE ......................................................................................................................................................... 96 8.3.3 UK ................................................................................................................................................................. 100 8.3.4 ITALY ............................................................................................................................................................. 103 8.3.5 SPAIN ............................................................................................................................................................ 107 8.3.6 REST OF EUROPE ............................................................................................................................................ 111 8.4 ASIA-PACIFIC ........................................................................................................................................................ 115 8.4.1 CHINA ............................................................................................................................................................ 121 8.4.2 INDIA ............................................................................................................................................................. 124 8.4.3 JAPAN ........................................................................................................................................................... 128 8.4.4 AUSTRALIA .................................................................................................................................................... 132 8.4.5 SOUTH KOREA ................................................................................................................................................ 135 8.4.6 REST OF ASIA-PACIFIC ................................................................................................................................... 140 8.5 REST OF THE WORLD ......................................................................................................................................... 144 8.5.1 MIDDLE EAST AND AFRICA ............................................................................................................................. 150 8.5.2 SOUTH AMERICA ............................................................................................................................................ 154 BY PRODUCT ..................................................................................................................................... 159 9 COMPETITIVE LANDSCAPE ........................................................................................................ 160 9.1 INTRODUCTION ................................................................................................................................................... 160 9.2 MARKET SHARE ANALYSIS, 2023 ...................................................................................................................... 160 9.3 COMPETITOR DASHBOARD .............................................................................................................................. 161 9.4 PUBLIC PLAYERS STOCK SUMMARY ............................................................................................................... 162 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ............................................................................... 162 9.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ........................................................................................... 163 9.1.1 PRODUCT LAUNCH ......................................................................................................................................... 163 9.1.2 PRODUCT APPROVAL ..................................................................................................................................... 163 9.1.3 AQUISITION .................................................................................................................................................... 163 9.1.4 AGREEMENT .................................................................................................................................................. 164 10 COMPANY PROFILES .................................................................................................................. 165 10.1 B. BRAUN SE .......................................................................................................................................................... 165 10.1.1 COMPANY OVERVIEW ..................................................................................................................................... 165 10.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 166 10.1.3 PRODUCTS OFFERED ...................................................................................................................................... 167 10.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 167 10.1.5 SWOT ANALYSIS ............................................................................................................................................ 168 10.1.6 KEY STRATEGIES ............................................................................................................................................ 168 10.2 XIROS LTD. ............................................................................................................................................................ 169 10.2.1 COMPANY OVERVIEW ..................................................................................................................................... 169 10.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 169 10.2.3 PRODUCTS OFFERED ...................................................................................................................................... 169 10.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 170 10.2.5 SWOT ANALYSIS ............................................................................................................................................ 170 10.2.6 KEY STRATEGIES ............................................................................................................................................ 170 10.3 ZIMMER BIOMET ................................................................................................................................................. 171 10.3.1 COMPANY OVERVIEW ..................................................................................................................................... 171 10.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 172 10.3.3 PRODUCT OFFERED ........................................................................................................................................ 172 10.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 173 10.3.5 KEY STRATEGIES ............................................................................................................................................ 173 10.4 CONMED CORPORATION .................................................................................................................................. 174 10.4.1 COMPANY OVERVIEW ..................................................................................................................................... 174 10.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 175 10.4.3 PRODUCTS OFFERED ...................................................................................................................................... 176 10.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 176 10.4.5 KEY STRATEGIES ............................................................................................................................................ 176 10.5 ARTHREX, INC. ..................................................................................................................................................... 177 10.5.1 COMPANY OVERVIEW ..................................................................................................................................... 177 10.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 177 10.5.3 PRODUCTS OFFERED ...................................................................................................................................... 177 10.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 178 10.5.5 KEY STRATEGIES ............................................................................................................................................ 178 10.6 JOHNSON & JOHNSON INC. ................................................................................................................................ 179 10.6.1 COMPANY OVERVIEW ..................................................................................................................................... 179 10.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 180 10.6.3 PRODUCTS OFFERED ...................................................................................................................................... 180 10.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 181 10.6.5 SWOT ANALYSIS ............................................................................................................................................ 181 10.6.6 KEY STRATEGIES ............................................................................................................................................ 182 10.7 INTEGRA LIFESCIENCES HOLDINGS CORPORATION .................................................................................. 183 10.7.1 COMPANY OVERVIEW ..................................................................................................................................... 183 10.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 184 10.7.3 PRODUCTS OFFERED ...................................................................................................................................... 184 10.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 185 10.7.5 SWOT ANALYSIS ............................................................................................................................................ 185 10.7.6 KEY STRATEGIES ............................................................................................................................................ 185 10.8 STRYKER ................................................................................................................................................................ 186 10.8.1 COMPANY OVERVIEW ..................................................................................................................................... 186 10.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 187 10.8.3 PRODUCTS OFFERED ...................................................................................................................................... 187 10.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 188 10.8.5 KEY STRATEGIES ............................................................................................................................................ 188 10.9 SMITH+NEPHEW .................................................................................................................................................. 189 10.9.1 COMPANY OVERVIEW ..................................................................................................................................... 189 10.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 190 10.9.3 PRODUCTS OFFERED ...................................................................................................................................... 190 10.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 191 10.9.5 KEY STRATEGIES ............................................................................................................................................ 191 10.10 BOSTON SCIENTIFIC CORPORATION .............................................................................................................. 192 10.10.1 COMPANY OVERVIEW ..................................................................................................................................... 192 10.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 193 10.10.3 PRODUCTS OFFERED ...................................................................................................................................... 193 10.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 193 10.10.5 KEY STRATEGIES ............................................................................................................................................ 194 11 DATA CITATIONS ......................................................................................................................... 195
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 36 TABLE 2 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 53 TABLE 3 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 54 TABLE 4 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY REGION, 2019–2032 (USD MILLION) 55 TABLE 5 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 55 TABLE 6 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 55 TABLE 7 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR ROTATOR CUFF TEARS, BY REGION, 2019–2032 (USD MILLION) 56 TABLE 8 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR BICEPS TENDONITIS, BY REGION, 2019–2032 (USD MILLION) 56 TABLE 9 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 57 TABLE 10 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY REGION, 2019–2032 (USD MILLION) 57 TABLE 11 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 58 TABLE 12 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 58 TABLE 13 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR ACL INJURIES, BY REGION, 2019–2032 (USD MILLION) 58 TABLE 14 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR MENISCAL TEARS, BY REGION, 2019–2032 (USD MILLION) 59 TABLE 15 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR COLLATERAL LIGAMENT INJURIES, BY REGION, 2019–2032 (USD MILLION) 59 TABLE 16 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 60 TABLE 17 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY REGION, 2019–2032 (USD MILLION) 60 TABLE 18 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 60 TABLE 19 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 61 TABLE 20 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP TENDONITIS, BY REGION, 2019–2032 (USD MILLION) 61 TABLE 21 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR LABRAL TEARS, BY REGION, 2019–2032 (USD MILLION) 62 TABLE 22 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 62 TABLE 23 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY REGION, 2019–2032 (USD MILLION) 63 TABLE 24 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 63 TABLE 25 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 63 TABLE 26 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR PLANTAR FASCIITIS, BY REGION, 2019–2032 (USD MILLION) 64 TABLE 27 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR ACHILLES TENDON RUPTURES, BY REGION, 2019–2032 (USD MILLION) 64 TABLE 28 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR TIBIAL TENDON DYSFUNCTION, BY REGION, 2019–2032 (USD MILLION) 65 TABLE 29 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 65 TABLE 30 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 67 TABLE 31 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD MILLION) 68 TABLE 32 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2019–2032 (USD MILLION) 69 TABLE 33 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SPECIALTY ORTHOPAEDIC CLINICS, BY REGION, 2019–2032 (USD MILLION) 69 TABLE 34 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY REGION, 2019-2032 (USD MILLION) 70 TABLE 35 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019-2032 (USD MILLION) 73 TABLE 36 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 73 TABLE 37 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 74 TABLE 38 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (USD MILLION) 74 TABLE 39 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (USD MILLION) 75 TABLE 40 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (USD MILLION) 75 TABLE 41 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (USD MILLION) 75 TABLE 42 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 76 TABLE 43 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 76 TABLE 44 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 76 TABLE 45 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 77 TABLE 46 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 77 TABLE 47 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019-2032 (USD MILLION) 77 TABLE 48 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 78 TABLE 49 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (USD MILLION) 78 TABLE 50 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (USD MILLION) 78 TABLE 51 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (USD MILLION) 79 TABLE 52 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (USD MILLION) 79 TABLE 53 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 79 TABLE 54 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 80 TABLE 55 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 80 TABLE 56 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 80 TABLE 57 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 81 TABLE 58 US: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019-2032 (USD MILLION) 81 TABLE 59 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 81 TABLE 60 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (USD MILLION) 82 TABLE 61 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (USD MILLION) 82 TABLE 62 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (USD MILLION) 82 TABLE 63 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (USD MILLION) 83 TABLE 64 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 83 TABLE 65 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 83 TABLE 66 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 84 TABLE 67 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 84 TABLE 68 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOR & ANKLE, BY TYPE, 2019-2032 (VOLUME IN NUMBER OF SURGERIES) 84 TABLE 69 CANADA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019-2032 (USD MILLION) 85 TABLE 70 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 87 TABLE 71 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 87 TABLE 72 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 88 TABLE 73 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 89 TABLE 74 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 89 TABLE 75 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 89 TABLE 76 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 90 TABLE 77 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 90 TABLE 78 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 90 TABLE 79 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 91 TABLE 80 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 91 TABLE 81 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 91 TABLE 82 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 92 TABLE 83 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 92 TABLE 84 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 92 TABLE 85 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 93 TABLE 86 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 93 TABLE 87 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 93 TABLE 88 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 94 TABLE 89 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 94 TABLE 90 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 94 TABLE 91 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 95 TABLE 92 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 95 TABLE 93 GERMANY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 96 TABLE 94 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 96 TABLE 95 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 96 TABLE 96 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 97 TABLE 97 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 97 TABLE 98 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 97 TABLE 99 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 98 TABLE 100 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 98 TABLE 101 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 98 TABLE 102 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 99 TABLE 103 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 99 TABLE 104 FRANCE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 99 TABLE 105 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 100 TABLE 106 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 100 TABLE 107 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 100 TABLE 108 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 101 TABLE 109 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 101 TABLE 110 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 101 TABLE 111 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 102 TABLE 112 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 102 TABLE 113 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 102 TABLE 114 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 103 TABLE 115 UK ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 103 TABLE 116 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 103 TABLE 117 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 104 TABLE 118 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 104 TABLE 119 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 104 TABLE 120 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 105 TABLE 121 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 105 TABLE 122 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 105 TABLE 123 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 106 TABLE 124 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 106 TABLE 125 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 106 TABLE 126 ITALY ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 107 TABLE 127 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 107 TABLE 128 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 107 TABLE 129 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 108 TABLE 130 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 108 TABLE 131 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 108 TABLE 132 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 109 TABLE 133 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 109 TABLE 134 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 109 TABLE 135 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 110 TABLE 136 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 110 TABLE 137 SPAIN ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 110 TABLE 138 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 111 TABLE 139 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 111 TABLE 140 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 111 TABLE 141 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 112 TABLE 142 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 112 TABLE 143 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 112 TABLE 144 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 113 TABLE 145 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 113 TABLE 146 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 113 TABLE 147 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, (VOLUME IN NUMBER OF SURGERIES), 2019–2032 114 TABLE 148 REST OF EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 114 TABLE 149 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 116 TABLE 150 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 116 TABLE 151 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 117 TABLE 152 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 117 TABLE 153 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 118 TABLE 154 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 118 TABLE 155 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 118 TABLE 156 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 119 TABLE 157 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 119 TABLE 158 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 119 TABLE 159 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 120 TABLE 160 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 120 TABLE 161 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 120 TABLE 162 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 121 TABLE 163 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 121 TABLE 164 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 121 TABLE 165 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 122 TABLE 166 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 122 TABLE 167 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 122 TABLE 168 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 123 TABLE 169 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 123 TABLE 170 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 123 TABLE 171 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 124 TABLE 172 CHINA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 124 TABLE 173 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 124 TABLE 174 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 125 TABLE 175 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 125 TABLE 176 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 125 TABLE 177 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 126 TABLE 178 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 126 TABLE 179 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 126 TABLE 180 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 127 TABLE 181 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 127 TABLE 182 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 127 TABLE 183 INDIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 128 TABLE 184 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 128 TABLE 185 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 128 TABLE 186 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 129 TABLE 187 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 129 TABLE 188 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 129 TABLE 189 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 130 TABLE 190 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 130 TABLE 191 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 130 TABLE 192 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 131 TABLE 193 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 131 TABLE 194 JAPAN: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 131 TABLE 195 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 132 TABLE 196 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 132 TABLE 197 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 132 TABLE 198 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 133 TABLE 199 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 133 TABLE 200 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 133 TABLE 201 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 134 TABLE 202 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 134 TABLE 203 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 134 TABLE 204 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 135 TABLE 205 AUSTRALIA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 135 TABLE 206 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 135 TABLE 207 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 136 TABLE 208 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 136 TABLE 209 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 136 TABLE 210 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 137 TABLE 211 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 137 TABLE 212 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 138 TABLE 213 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 138 TABLE 214 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 138 TABLE 215 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 139 TABLE 216 SOUTH KOREA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 139 TABLE 217 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 140 TABLE 218 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 140 TABLE 219 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 140 TABLE 220 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 141 TABLE 221 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 141 TABLE 222 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 141 TABLE 223 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 142 TABLE 224 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 142 TABLE 225 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 142 TABLE 226 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 143 TABLE 227 REST OF ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 143 TABLE 228 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 145 TABLE 229 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 145 TABLE 230 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 146 TABLE 231 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 146 TABLE 232 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 147 TABLE 233 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 147 TABLE 234 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 147 TABLE 235 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 148 TABLE 236 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 148 TABLE 237 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 149 TABLE 238 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 149 TABLE 239 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 149 TABLE 240 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 150 TABLE 241 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 150 TABLE 242 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 151 TABLE 243 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 151 TABLE 244 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 151 TABLE 245 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 152 TABLE 246 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 152 TABLE 247 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 152 TABLE 248 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 153 TABLE 249 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 153 TABLE 250 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 153 TABLE 251 MIDDLE EAST AND AFRICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 154 TABLE 252 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 154 TABLE 253 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (USD MILLION) 155 TABLE 254 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (USD MILLION) 155 TABLE 255 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (USD MILLION) 155 TABLE 256 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (USD MILLION) 156 TABLE 257 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 156 TABLE 258 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR SHOULDER, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 156 TABLE 259 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR KNEE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 157 TABLE 260 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR HIP, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 157 TABLE 261 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, FOR FOOT AND ANKLE, BY TYPE, 2019–2032 (VOLUME IN NUMBER OF SURGERIES) 157 TABLE 262 SOUTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2019–2032 (USD MILLION) 158 TABLE 263 PRODUCT LAUNCH 163 TABLE 264 PRODUCT APPROVAL 163 TABLE 265 AQUISITION 163 TABLE 266 AGREEMENT 164 TABLE 267 B. BRAUN SE: PRODUCTS OFFERED 167 TABLE 268 XIROS LTD.: PRODUCTS OFFERED 169 TABLE 269 ZIMMER BIOMET: PRODUCTS OFFERED 172 TABLE 270 ZIMMER BIOMET: KEY DEVELOPMENTS 173 TABLE 271 CONMED CORPORATION: PRODUCTS OFFERED 176 TABLE 272 CONMED CORPORATION: KEY DEVELOPMENTS 176 TABLE 273 ARTHREX, INC.: PRODUCTS OFFERED 177 TABLE 274 ARTHREX, INC.: KEY DEVELOPMENTS 178 TABLE 275 JOHNSON & JOHNSON INC.: PRODUCTS OFFERED 180 TABLE 276 STRYKER: KEY DEVELOPMENTS 181 TABLE 277 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT OFFERED 184 TABLE 278 STRYKER: PRODUCT OFFERED 187 TABLE 279 STRYKER: KEY DEVELOPMENTS 188 TABLE 280 SMITH+NEPHEW: PRODUCTS OFFERED 190 TABLE 281 SMITH+NEPHEW: PRODUCTS OFFERED 191 TABLE 282 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 193 LIST OF FIGURES FIGURE 1 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET: STRUCTURE 24 FIGURE 2 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032) 40 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 43 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032) 44 FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET 47 FIGURE 6 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION) 53 FIGURE 7 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE (%), BY APPLICATION, 2023 54 FIGURE 8 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY END USER, 2023 & 2032 (USD MILLION) 67 FIGURE 9 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE (%), BY END USER, 2023 68 FIGURE 10 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY REGION, 2023 & 2032 (USD MILLION) 70 FIGURE 11 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE (%), BY COUNTRY, 2023 71 FIGURE 12 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) 73 FIGURE 13 NORTH AMERICA: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE (%), BY COUNTRY, 2023 74 FIGURE 14 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) 86 FIGURE 15 EUROPE ORTHOPAEDIC SOFT TISSUE REPAIR SHARE (%), BY COUNTRY, 2023 88 FIGURE 16 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) 115 FIGURE 17 ASIA-PACIFIC: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE, BY COUNTRY, 2023 (%) 117 FIGURE 18 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) 145 FIGURE 19 REST OF THE WORLD: ORTHOPAEDIC SOFT TISSUE REPAIR MARKET SHARE, BY COUNTRY, 2023 (%) 146 FIGURE 20 GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023 160 FIGURE 21 COMPETITOR DASHBOARD: GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET 161 FIGURE 22 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT 166 FIGURE 23 B. BRAUN SE: KEY DEVELOPMENTS 167 FIGURE 24 B. BRAUN SE: SWOT ANALYSIS 168 FIGURE 25 XIROS LTD.: SWOT ANALYSIS 170 FIGURE 26 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT 172 FIGURE 27 CONMED CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 175 FIGURE 28 JOHNSON & JOHNSON INC.: FINANCIAL OVERVIEW SNAPSHOT 180 FIGURE 29 JOHNSON & JOHNSON INC.: SWOT ANALYSIS 181 FIGURE 30 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 184 FIGURE 31 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: SWOT ANALYSIS 185 FIGURE 32 STRYKER: FINANCIAL OVERVIEW SNAPSHOT 187 FIGURE 33 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT 190 FIGURE 34 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 193

提及公司

Braun SE (Germany)Xiros Ltd. (UK)Zimmer Biomet (US)CONMED Corporation (US)ArthrexInc. (US)Johnson & Johnson Inc. (US)Integra Lifesciences Holdings Corporation (US)Stryker (US)Smith+Nephew (UK)and Boston Scientific Corporation (US)

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們